Skip to main content

Table 1 Clinical and pathological findings of the patients affected by malignant melanoma

From: Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions

Patient n. Age Sex Site Thickness (mm) S-LFN LFN
Thickness ≤ 1 mm       
1. 58 F Groin 0.7 -  
2. 34 F Thigh 0.3 - -
3. 41 M Underscapular 0.88 -  
4. 32 M Costal 0.4 -  
5. 50 M Upperscapular 0.3 - +
6. 34 F Back 0.5 + (itc) -
7. 66 M Lumbar 0.5 + (itc) -
8. 64 M Paravertebral 0.5 -  
9. 63 F Leg 1 -  
10. 70 M Thorax 0.5 -  
Thickness > 1 mm       
1. 36 F Thigh 1.2 -  
2. 55 F Knee 1.2 -  
3. 31 M Back 1.4 + (itc) -
4. 63 F Forearm 1.1 -  
5. 35 F Thigh 2 + -
6. 30 F Thigh 1.7 -  
7. 33 M Arm 1.4 -  
8. 62 F Arm 3 -  
9. 38 F Pubis 2.7 + -
10. 59 F Leg 2 -  
  1. S-LFN, sentinel lymph node; LFN, regional lymphadenectomy; itc, isolated tumour cells